Zigakibart clinical trials

Atrasentan in Patients With IgA Nephropathy

This study is testing a new medicine, atrasentan, for people with a kidney disease called IgA nephropathy. It compares atrasentan to a dummy pill (placebo) to see if it can slow down kidney damage and improve kidney function.